MediLink Therapeutics Archives - Inside Precision Medicine

Inside Precision Medicine Roche Inks $2B+ Deal with MOMA for New Cancer Targets

Translucent robotic looking hand holding a test tube next to a screen showing code and a digital pill to symbolize the use of AI to develop new protein phase separation drugs

News & Features

Roche Inks $2B+ Deal with MOMA for New Cancer Targets

January 5, 2024

Related Content

FDA Clears Sangamo’s ST-503 for Chronic Neuropathic Pain Clinical Trials

FDA Clears Sangamo’s ST-503 for Chronic Neuropathic Pain Clinical Trials

Multimodal Machine Learning Model Forecasts CDK4/6 Inhibitor Response in Metastatic Breast Cancer

Multimodal Machine Learning Model Forecasts CDK4/6 Inhibitor Response in Metastatic Breast Cancer

New Combination of Anti-CXCR4 and Anti-PD1 Therapy Shows Promise for Liver Cancer Treatment

New Combination of Anti-CXCR4 and Anti-PD1 Therapy Shows Promise for Liver Cancer Treatment

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine